NFKB1 and systemic lupus erythematosus: Continuous activation of NF-κB signalling pathway and persistent inflammatory response can cause pathological changes in the body, such as systemic lupus erythematosus, rheumatoid arthritis, cancer, and other diseases associated with inflammation.